Pharmaceutical Products Registration Requirements for ASEAN and GCC Countries
Abstract
Registration of pharmaceutical products is a challenge and an important task in regulated, semi regulated as well as rest of the world countries. Although the requirements are harmonized in regulated countries by Common Technical Document (CTD) filing, yet others have enormous diversity in requirements. The purpose of the present study is to understand the requirements for registration of drug products in countries like the Association of South East Asian Nation (ASEAN) and Gulf Cooperation Council (GCC).In the ASEAN and GCC region, A-CTD filling procedure and CTD format is used, respectively. The optimization in requirements is mandatory and can be judged by the incidence of higher cost involved in the availability of drugs, research and development facilities. For better treatment, safety and efficacy the drugs must be justified and rationalized for public security. The study also provides the challenges and barriers faced by the emerging markets (ASEAN). The commercial significance of markets is increasing globally. It is vital for pharmaceutical industry to cope with the regulatory requirements for betterment of public and ensure their place in the market.
Keywords: CTD, ACTD, ASEAN, GCC
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
